Delaware Healthcare Fund Manager Performance Evaluation

DLHCX Fund  USD 24.61  0.20  0.82%   
The fund shows a Beta (market volatility) of 0.68, which means possible diversification benefits within a given portfolio. As returns on the market increase, Delaware Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Delaware Healthcare is expected to be smaller as well.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Delaware Healthcare Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
...more
Expense Ratio Date29th of July 2022
Expense Ratio1.9600
  

Delaware Healthcare Relative Risk vs. Return Landscape

If you would invest  2,718  in Delaware Healthcare Fund on August 24, 2024 and sell it today you would lose (257.00) from holding Delaware Healthcare Fund or give up 9.46% of portfolio value over 90 days. Delaware Healthcare Fund is currently producing negative expected returns and takes up 0.8002% volatility of returns over 90 trading days. Put another way, 7% of traded mutual funds are less volatile than Delaware, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Delaware Healthcare is expected to under-perform the market. In addition to that, the company is 1.04 times more volatile than its market benchmark. It trades about -0.19 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

Delaware Healthcare Current Valuation

Fairly Valued
Today
24.61
Please note that Delaware Healthcare's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Delaware Healthcare shows a prevailing Real Value of $24.73 per share. The current price of the fund is $24.61. We determine the value of Delaware Healthcare from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.
Since Delaware Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Delaware Mutual Fund. However, Delaware Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  24.61 Real  24.73 Hype  24.41 Naive  23.68
The intrinsic value of Delaware Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Delaware Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
24.73
Real Value
25.52
Upside
Estimating the potential upside or downside of Delaware Healthcare Fund helps investors to forecast how Delaware mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Delaware Healthcare more accurately as focusing exclusively on Delaware Healthcare's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.9625.3726.79
Details
Hype
Prediction
LowEstimatedHigh
23.6224.4125.20
Details
Naive
Forecast
LowNext ValueHigh
22.8923.6824.47
Details

Delaware Healthcare Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Delaware Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Delaware Healthcare Fund, and traders can use it to determine the average amount a Delaware Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1898

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDLHCX

Estimated Market Risk

 0.8
  actual daily
7
93% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.19
  actual daily
0
Most of other assets perform better
Based on monthly moving average Delaware Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Delaware Healthcare by adding Delaware Healthcare to a well-diversified portfolio.

Delaware Healthcare Fundamentals Growth

Delaware Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Delaware Healthcare, and Delaware Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Delaware Mutual Fund performance.

About Delaware Healthcare Performance

Evaluating Delaware Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Delaware Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Delaware Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Under normal circumstances, the fund will invest at least 80 percent of its assets, plus the amount of any borrowings for investment purposes, in the equity securities of healthcare companies, meaning companies that develop, produce, or distribute products or services related to the healthcare or medical industries and derive a substantial portion, that is, more than 50, of their sales from products and services in the healthcare industry . It is non-diversified.

Things to note about Delaware Healthcare performance evaluation

Checking the ongoing alerts about Delaware Healthcare for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Delaware Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Delaware Healthcare generated a negative expected return over the last 90 days
The fund retains 95.6% of its assets under management (AUM) in equities
Evaluating Delaware Healthcare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Delaware Healthcare's mutual fund performance include:
  • Analyzing Delaware Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Delaware Healthcare's stock is overvalued or undervalued compared to its peers.
  • Examining Delaware Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Delaware Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Delaware Healthcare's management team can help you assess the Mutual Fund's leadership.
  • Pay attention to analyst opinions and ratings of Delaware Healthcare's mutual fund. These opinions can provide insight into Delaware Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Delaware Healthcare's mutual fund performance is not an exact science, and many factors can impact Delaware Healthcare's mutual fund market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Delaware Mutual Fund

Delaware Healthcare financial ratios help investors to determine whether Delaware Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delaware with respect to the benefits of owning Delaware Healthcare security.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities